Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Journal of the American College of Cardiology|December 19, 2003
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trialCarl J Pepine, Jean-Lucien Rouleau, Karen Annis, et al.
Circulation. Heart Failure|July 17, 2012
Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure TrialEileen O'Meara, Paul Khairy, Malorie Chabot Blanchet, et al.
European Journal of Heart Failure|May 10, 2026
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trialsGuiomar Mendieta, Paul M Ridker, Barry A Borlaug, et al.
The Canadian Journal of Cardiology|July 28, 2011
Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristicsBernard Thibault, François Harel, Anique Ducharme, et al.
Hypertension (Dallas, Tex. : 1979)|April 25, 2007
Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudyGary F Mitchell, Mark E Dunlap, Wayne Warnica, et al.
Circulation|November 23, 2011
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 millisecondsBernard Thibault, Anique Ducharme, François Harel, et al.
Pharmacogenetics and Genomics|February 11, 2012
PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipientsKim Lachance, Amina Barhdadi, Ian Mongrain, et al.
The Annals of Pharmacotherapy|July 3, 2008
Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartanSimon de Denus, Marcin Zakrzewski-Jakubiak, Marie-Pierre Dubé, et al.
International Journal of Vascular Medicine|April 11, 2014
Changes in cardiopulmonary reserve and peripheral arterial function concomitantly with subclinical inflammation and oxidative stress in patients with heart failure with preserved ejection fractionDamien Vitiello, François Harel, Rhian M Touyz, et al.
American Heart Journal|April 29, 2006
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) programAnique Ducharme, Karl Swedberg, Marc A Pfeffer, et al.
Pageof 17